Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02561234
Title A Multiple Dose, Dose Escalation Trial of AEB1102 in Patients With Advanced Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Aeglea Biotherapeutics
Indications

Advanced Solid Tumor

lung small cell carcinoma

melanoma

uveal melanoma

Therapies

Pegzilarginase

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Pinnacle Research Phoenix Arizona 85258 United States Details
UCLA Los Angeles California 90024 United States Details
University of Colorado Aurora Colorado 80045 United States Details
Research Center: Mid Florida Hematology/Oncology Centers Orange City Florida 32763 United States Details
Dana Farber Boston Massachusetts 02114 United States Details
Massachusetts General Boston Massachusetts 02114 United States Details
Washington University Saint Louis Missouri 93110 United States Details
Columbia University New York New York 10032 United States Details
Providence Cancer Center Portland Oregon 97213 United States Details
University of Pittsburgh Pittsburgh Pennsylvania 15232 United States Details
UTSW Dallas Texas 75390-8852 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field